Assertio Holdings, Inc.
Index- P/E45.38 EPS (ttm)0.07 Insider Own2.80% Shs Outstand45.20M Perf Week7.08%
Market Cap135.29M Forward P/E10.28 EPS next Y0.29 Insider Trans-9.06% Shs Float44.51M Perf Month-1.99%
Income3.20M PEG1.82 EPS next Q0.08 Inst Own21.20% Short Float1.79% Perf Quarter6.50%
Sales120.70M P/S1.12 EPS this Y97.20% Inst Trans30.55% Short Ratio0.81 Perf Half Y52.85%
Book/sh2.47 P/B1.19 EPS next Y-28.78% ROA1.00% Target Price5.83 Perf Year89.10%
Cash/sh1.34 P/C2.20 EPS next 5Y25.00% ROE3.20% 52W Range0.85 - 3.52 Perf YTD35.32%
Dividend- P/FCF- EPS past 5Y65.20% ROI4.90% 52W High-10.63% Beta1.54
Dividend %- Quick Ratio0.80 Sales past 5Y-24.60% Gross Margin87.30% 52W Low269.48% ATR0.19
Employees19 Current Ratio0.90 Sales Q/Q36.20% Oper. Margin11.20% RSI (14)60.99 Volatility5.97% 6.58%
OptionableYes Debt/Eq0.66 EPS Q/Q66.40% Profit Margin2.70% Rel Volume1.88 Prev Close2.95
ShortableYes LT Debt/Eq0.55 EarningsMay 09 AMC Payout0.00% Avg Volume982.03K Price3.14
Recom2.00 SMA207.22% SMA5016.09% SMA20048.01% Volume1,826,700 Change6.61%
Nov-30-18Downgrade Mizuho Buy → Neutral
Jun-21-22 11:27AM  
Jun-10-22 06:15PM  
Jun-07-22 10:00AM  
Jun-01-22 08:30AM  
May-30-22 09:40AM  
May-16-22 01:20PM  
May-13-22 09:40AM  
May-10-22 07:00AM  
May-09-22 05:15PM  
May-03-22 06:15PM  
Apr-28-22 08:07AM  
Apr-26-22 01:20PM  
Apr-22-22 09:00AM  
Apr-14-22 03:38PM  
Apr-13-22 04:55PM  
Apr-11-22 08:33AM  
Apr-08-22 02:29PM  
Apr-01-22 06:19AM  
Mar-31-22 09:00AM  
Mar-28-22 09:40AM  
Mar-25-22 10:27AM  
Mar-14-22 06:45AM  
Mar-11-22 08:20AM  
Mar-09-22 09:45AM  
Mar-03-22 04:43AM  
Mar-02-22 09:30AM  
Feb-21-22 09:40AM  
Jan-28-22 10:07AM  
Jan-18-22 07:30AM  
Jan-10-22 09:40AM  
Dec-27-21 12:48PM  
Dec-20-21 08:49AM  
Dec-15-21 05:35PM  
Dec-07-21 04:30PM  
Nov-12-21 04:05PM  
Nov-05-21 12:00PM  
Nov-04-21 05:45PM  
Oct-28-21 03:06PM  
Oct-26-21 09:05AM  
Oct-04-21 09:05AM  
Sep-10-21 02:44PM  
Sep-09-21 06:01PM  
Aug-05-21 04:01PM  
Jul-20-21 09:00AM  
Jun-30-21 09:56AM  
Jun-04-21 09:27AM  
May-21-21 01:15PM  
May-17-21 06:32AM  
May-06-21 04:01PM  
May-05-21 09:00AM  
Apr-22-21 09:25AM  
Mar-11-21 04:01PM  
Mar-04-21 10:28AM  
Mar-01-21 04:01PM  
Feb-25-21 06:00AM  
Feb-22-21 08:48AM  
Feb-18-21 04:01PM  
Feb-12-21 04:05PM  
Feb-10-21 12:01AM  
Feb-09-21 04:05PM  
Feb-05-21 12:05AM  
Feb-03-21 04:01PM  
Feb-01-21 08:00AM  
Jan-15-21 04:27AM  
Jan-12-21 08:51AM  
Jan-11-21 07:30AM  
Jan-08-21 08:00AM  
Dec-29-20 04:05PM  
Dec-15-20 09:00AM  
Dec-12-20 11:35PM  
Dec-10-20 03:18AM  
Dec-09-20 07:30AM  
Nov-19-20 08:00AM  
Nov-17-20 08:00AM  
Nov-10-20 04:01PM  
Nov-06-20 07:45AM  
Nov-04-20 09:47AM  
Oct-30-20 12:30PM  
Oct-27-20 06:30AM  
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tyree James LDirectorMay 12Sale2.3644,643105,170210,451May 16 07:20 PM
MCKEE WILLIAMDirectorMay 12Sale2.3522,32252,488229,586May 16 07:16 PM
Peisert Daniel A.President and CEOApr 11Sale3.5026,39192,368158,402Apr 13 05:39 PM
Peisert Daniel A.President and CEOApr 05Sale3.5034,518120,813184,793Apr 07 06:23 PM
Mason Heather LDirectorFeb 18Option Exercise0.003,5980159,455Feb 18 05:44 PM
Schwichtenberg PaulSVP and CFOFeb 12Option Exercise0.004,934066,494Feb 16 05:30 PM
Peisert Daniel A.President and CEOFeb 12Option Exercise0.006,8970222,091Feb 16 05:24 PM
Peisert Daniel A.President and CEOFeb 11Option Exercise0.00189,3940298,821Feb 14 04:33 PM
Schwichtenberg PaulSVP and CFOFeb 11Option Exercise0.0047,349081,442Feb 14 04:26 PM
Patel AjaySVP and CAOFeb 11Option Exercise0.0047,349074,389Feb 14 04:29 PM
Patel AjaySVP and CAOFeb 04Option Exercise0.004,983028,971Feb 08 02:34 PM
Schwichtenberg PaulSVP and CFOFeb 04Option Exercise0.009,966037,531Feb 08 02:31 PM
Peisert Daniel A.President and CEOFeb 04Option Exercise0.0030,9690124,524Feb 08 02:29 PM
Peisert Daniel A.President and CEODec 01Option Exercise0.002,089094,119Dec 02 06:34 PM
Peisert Daniel A.President and CEOSep 18Option Exercise0.002,905092,881Sep 20 06:27 PM
Peisert Daniel A.President and CEOAug 15Option Exercise0.00453090,108Aug 17 05:24 PM
Patel AjaySVP and CAOJul 31Option Exercise0.008,060026,260Aug 03 05:03 PM